Position in INVA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$6,203,688
+$201,448 QoQ
Shares Held
273,170
+6.0% QoQ
Ownership
0.378%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#45
of 307 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FRANKLIN RESOURCES INC holds $9,179,114,031 across 176 Biotechnology names. INVA ranks #87 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,771,839 | $1,728,352,485 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,347,253 | $1,662,680,977 | |
| 3 | ASND |
Ascendis Pharma A/S
|
1,862,503 | $496,766,798 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
2,040,250 | $491,639,040 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,488,394 | $278,746,426 | |
| 6 | INSM |
INSMED Inc
|
2,273,222 | $242,370,927 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
752,044 | $237,713,585 | |
| 8 | ARGX |
Argenx SE
|
224,930 | $208,683,303 |
All Filings in INVA
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,203,688 | 273,170 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $6,002,240 | 257,607 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $27,832,893 | 1,392,341 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $45,584,501 | 2,497,781 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $56,812,870 | 2,827,918 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $71,975,190 | 3,969,950 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $76,900,420 | 4,432,301 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $130,246,816 | 6,745,045 | Shares | Defined | 2024-11-27 | |
| 2024-06-30 | $108,524,587 | 6,617,353 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $95,579,654 | 6,271,631 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $732,769 | 45,684 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $581,053 | 44,731 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $240,633 | 18,903 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $207,527 | 18,447 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $241,798 | 18,249 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $212,218 | 18,279 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $265,147 | 17,964 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $805,965 | 41,652 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $702,816 | 40,743 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $689,972 | 41,291 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $223,074 | 16,635 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $206,041 | 17,242 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $213,628 | 17,242 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $179,729 | 17,199 | Shares | Defined | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||